（文章来源：证券日报） 证券日报网讯 11月28日晚间，金陵药业发布公告称，2025年11月28日，公司召开第九届董事会第二十 二次会议，审议通过了《关于南京梅山医院投资改扩建项目的议案》，同意公司控股子公司南京梅山医 院投资89，329.63万元（最终以实际投资金额为准）实施医院改扩建项目。 ...

格隆汇11月28日丨金陵药业(000919.SZ)公布，控股子公司南京梅山医院有限责任公司（简称"南京梅山 医院"或"医院"）为更好地满足辐射区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与 服务能力，拟投资89,329.63万元（最终以实际投资金额为准）实施医院改扩建项目。项目建设内容：主 要包括拆除工程、改造工程、新建工程、室外工程等土建安装工程，以及医疗专项和医疗设备购置。主 体工程为新建的门急诊医技病房综合楼，该工程共计地上12层，地下2层，主要功能为门诊、急诊、医 技及病房等。 ...

人民财讯11月28日电，金陵药业（000919）11月28日公告，控股子公司南京梅山医院为更好地满足辐射 区域内民众日益增长的健康需求，进一步提升医院医疗设施水平与服务能力，拟投资8.93亿元实施医院 改扩建项目。 ...

Core Insights - The conference focused on advancements in geriatric pharmacy and oncology pharmacy, addressing challenges and opportunities in grassroots medication management [7][10] - The event was organized by the Jinan Pharmaceutical Association and hosted by the Fifth People's Hospital of Jinan, highlighting the importance of collaboration among healthcare professionals [1][9] Group 1: Conference Overview - The academic meeting was successfully held at the Fifth People's Hospital of Jinan, with over 90 participants including key figures from the hospital and the pharmaceutical association [1] - The meeting included an opening ceremony and specialized forums, emphasizing high-level academic exchanges [7] Group 2: Key Speakers and Contributions - Keynote speeches were delivered by prominent figures such as An Jian, the hospital's Party Secretary, and Zang Hengchang, Vice President of the Jinan Pharmaceutical Association, who emphasized the importance of enhancing pharmaceutical services [9][5] - Yang Guangcheng, the hospital's Vice President, discussed the achievements of the pharmacy department in quality control, research innovation, and community support [5] Group 3: Specialized Topics - The specialized forum featured discussions on topics such as pharmaceutical care for chronic diseases and patient education in oncology, led by experts from various hospitals [10] - Presentations included insights on medication management for elderly patients and the importance of pharmacogenomics in ensuring patient safety [10] Group 4: Conclusion and Future Directions - The conference concluded with a summary by Tian Guizhen, who expressed gratitude to participants and highlighted the event's role in shaping the future of grassroots pharmaceutical services [12] - The meeting aimed to foster collaboration among pharmaceutical professionals to enhance medication safety and patient health outcomes [12]

Core Viewpoint - Corning Hospital (02120) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1: Buyback Details - The company will repurchase 22,100 shares at a total cost of HKD 245,300 [1] - The buyback price ranges from HKD 10.98 to HKD 11.23 per share [1]

Core Insights - The conference focused on the challenges and opportunities presented by the deepening national medical insurance reform, discussing innovative paths for high-quality hospital development [1][2] - Over 140 representatives from various medical institutions attended, indicating strong engagement from the healthcare community [1] - Experts provided insights on payment reform, hospital operation management, and the collaborative development of medical insurance and healthcare [1] Group 1 - The conference was hosted by Weifang People's Hospital and included key figures such as the hospital's president and vice presidents [1] - Notable experts from both national and provincial levels were invited to share their knowledge and experiences [1] - The discussion segment featured representatives from various hospitals sharing successful experiences and innovative practices regarding current medical insurance reform challenges [1] Group 2 - The annual meeting was described as a high-level academic event aimed at building consensus and looking towards the future of the industry [2] - Weifang People's Hospital, as the main unit, expressed commitment to collaborating with member units to enhance medical insurance management in the city [2] - The goal is to provide better quality and more efficient medical services to insured individuals [2]

"西苑医院将与苏州市中医医院构建起'一院两区'管理模式，通过资源共享与流程互通，为市民搭 建更加灵活、便捷的就医选择。"苏州市中医医院党委书记、西苑医院苏州医院院长贾秋放介绍。后 续，西苑医院20多位各科室主任、学科带头人等权威专家将定期来苏州，携手苏州市中医医院的本地名 医，形成"京派名医"与"吴门大家"强强联合阵容。 西苑医院苏州医院是苏州市政府与中国中医科学院西苑医院合作共建的三级公立中医医院，医院规 划床位1000张、总建筑面积超20万平方米，2023年7月正式获批国家第五批区域医疗中心。 试运行期间，30个门诊科室覆盖心血管、骨伤、治未病、脾胃病等核心及特色科室。依托西苑医院 的实力，西苑医院苏州医院将重点打造以泛血管疾病为核心的心血管病科、脑病科、周围血管病科等学 科，为患者提供中西医结合诊疗方案。目前，病房和急诊正在进行最后的设备和流程调试，预计12月份 陆续启用。 11月26日，苏州首个国家区域医疗中心——中国中医科学院西苑医院苏州医院门诊试运行，首批开 放30个门诊科室，推出前5天免收挂号费、开展大型义诊等惠民举措，让市民在家门口看上"国字号"专 家。 ...

Core Viewpoint - The establishment of the weight management center at Yuebei People's Hospital marks a shift from a treatment-focused approach to a health-centered model in managing overweight and obesity, aligning with the national "Healthy China 2030" strategy and the "Weight Management Year" initiative [2][4][19]. Group 1: Multidisciplinary Collaboration - The weight management center integrates various specialties, including endocrinology, traditional Chinese medicine, nutrition, and psychology, to provide comprehensive management services for overweight and obese individuals [4][7]. - The center employs a full-cycle management model that transitions from single-disease treatment to disease prevention, emphasizing long-term health management [7]. Group 2: Personalized Management Plans - The center conducts multidimensional assessments, including body composition analysis and metabolic function tests, to create individualized intervention plans for patients [8]. - These plans encompass personalized dietary recommendations, exercise prescriptions, and medication advice, along with dynamic health records for ongoing management [8]. Group 3: Traditional Chinese Medicine Interventions - The center offers various traditional Chinese medicine interventions, such as acupuncture, moxibustion, and herbal therapy, tailored to different body types to promote preventive health measures [9]. - The approach aims to enhance the overall weight management experience by integrating traditional practices with modern medical strategies [9]. Group 4: National Strategy and Goals - The "Weight Management Year" initiative aims to significantly improve public awareness and skills in weight management by 2026, with a target of reducing the annual obesity rate increase by 10% [19]. - By 2030, the initiative seeks to establish a supportive environment for weight management, promote healthy lifestyles, and mitigate the rising trend of overweight and obesity in the population [19].

患者使用的是一款介入人工生物心脏瓣膜及配套经心尖介入器，根据院方的情况说明，该产品是经公开招投标程序采购的中标产品，采购渠道合法合规， 采购价分别为26万元、2万元。院方严格执行国家医用耗材"零加成"政策，按实际采购价28万元向患者收取费用。 根据院方的情况说明，该产品是经公开招投标程序采购的中标产品，采购渠道合法合规。 11月26日，西安交通大学第一附属医院（下称"西安交大一附院"）发布的一则情况说明引发业内关注。该院提到一起介入主动脉瓣置换术（TAVR）导致 的医患纠纷。 手术发生于5年前，当时一名70岁的患者因心脏瓣膜病、主动脉瓣狭窄等疾病入院治疗，该院心外科为患者实施了TAVR手术，患者出院后不久离世。患 者家属对西安交大一附院诊疗行为提出质疑，并向法院提起诉讼。目前，诉讼案件正在审理中。 患者家属主要针对相关医疗费用提出起诉，声称医疗过程中使用的植入器械"出厂价3万多元，却向患者收取28万元"。据医院方面的情况说明，患者住院 期间总医疗费用61.32万元，其中医保基金支付29.32万元，个人自费32万元。自费部分中，介入人工生物心脏瓣膜相关费用28万元，占自费总额的 87.5%。 不过患者家属通过其 ...

Core Viewpoint - Morgan Stanley predicts that the Indian benchmark Nifty 50 index is expected to rise to 30,000 points by the end of 2026, an increase of approximately 15% from current levels, driven by tax cuts and interest rate reductions [1] Market Performance - The Indian stock market experienced its strongest rebound in five months, with the Nifty 50 index surging 1.24% to 26,205.3 points, marking the highest closing level in 14 months [1] - The BSE Sensex index also rose 1.21% to 86,609.51 points, ending a three-day decline, with both indices recording their best single-day performance in five months [2] Economic Drivers - Morgan Stanley's report indicates that the Reserve Bank of India is expected to cut interest rates by 25 basis points in December, alongside recent tax cuts that have begun to boost consumption, corporate debt growth, and automobile sales, collectively driving domestic demand [3][4] - The report highlights that while the current valuation of the Indian stock market is at a premium compared to other emerging markets, it has fallen below long-term averages after 14 months of underperformance [4] Trade Relations - Analysts believe that the likelihood of a US-India trade agreement is high, which could lead to a short-term revaluation of the stock market. Increased oil imports from the US and reduced purchases from Russia may eliminate the possibility of punitive tariffs from the US [5] - The potential removal of the additional 25% tariff is expected to boost investor confidence, attract foreign capital, support the rupee, and benefit the IT and pharmaceutical sectors [5] Sector Preferences - Morgan Stanley maintains an "overweight" rating on sectors such as materials, financials, consumer goods, hospitals, real estate, defense, and power, while holding a "underweight" stance on IT and pharmaceutical sectors [7] - The analysis suggests that industries benefiting from domestic consumption growth and infrastructure development will perform better, with the financial sector poised to gain from the interest rate cycle and increased corporate debt demand [7]